KPV has promising anti-inflammatory properties and strong antimicrobial properties, too
In adults with obesity and knee osteoarthritis, retatrutide delivered: 9mg dose: 26.4% body weight reduction at 68 weeks 12mg dose: 28.7% body weight reduction at 68 weeks (average of 71.2 pounds lost) Placebo: 2.1% body weight reduction The 68-week timeframe is longer than the Phase 2 trial, which partially explains the higher numbers
High Bioavailability: With particle sizes ranging from 30 to 150 nm, the serum ensures optimal absorption, delivering maximum efficacy
This results in decreased expression of the articulin CD2AP and the podocyte cytoskeleton protein synaptopodin, while increased expression of the transcription factor snail and nerphrin, a marker protein of podocyte injury, ultimately leads to podocyte actin skeleton remodeling and cell migration[94]
Some users report improved mental clarity within 12 weeks, while others may take 48 weeks of consistent use to notice cumulative benefits